According to the report published by the Market Research Store, global demand for the adiponectin testing market was estimated at approximately USD 1,905.2 Million in 2020 and is expected to generate revenue of around USD 2,600.6 Million by end of 2026, growing at a CAGR of around 5.6% between 2021 and 2026.
Global Adiponectin Testing Market: Overview
Adiponectin has shown significant clinical potential as an adipocyte-derived protein in the pathophysiology of metabolic diseases and coronary artery disease. A higher level of circulating adiponectin is associated with a high risk of pre-diabetes, metabolic syndrome, and adverse cardiovascular events. Numerous studies completed on animal models have highlighted these findings, a key evolutionary factor for the adiponectin testing market. Moreover, the health care industry has also focused on profiting from the testing on animals where insulin-sensitizing, antiatherogenic, anti-inflammatory, cardiomyocyte-protective properties of the hormone are utilized.
Over the last few decades, considerable efforts have been made in searching for the use of adiponectin testing as a potential biomarker in insulin sensitivity and obesity in human patients. Still, the test isn’t considered a key determinant in positively identifying metabolic disease risks in patients. The key application areas of adiponectin testing are for diagnostics and research. The methods used consist of enzyme-linked immunosorbent assay (ELISA) and enzyme immunoassay kits.
| REPORT SNAPSHOT & REPORTING DATA TIMEFRAME | |
|---|---|
| Parameter | Details |
| Historical Date ( Actual Data) | 2016 - 2020 |
| Base Year Data | 2020 |
| Current Year Data | 2021 |
| Projected Data | 2021 - 2026 |
The drive for the adiponectin testing market stems from the increasing potential of adipose-derived products as a drug target for treating as well as preventing cardio metabolic diseases. The latest prospects have appeared in the market from the growing body of research on understanding the pathophysiology of metabolic syndrome. This syndrome has evoked severe concern in the healthcare systems across the world. The marked mortality rate of diseases caused by this syndrome, such as cardiovascular disease (CVD), type 2diabetes, and non-alcoholic fatty liver disease (NAFLD) has expanded the range of the adiponectin testing market.
Global Adiponectin Testing Market: Growth Factor
In recent years, drug manufacturers have been focusing on new drug targets for insulin resistance (IR)-related metabolic disorders, which is driving the industry interest in adiponectin testing. However, the rising demand for the population for the diagnosis of hypoadiponectinemia has boosted the possibility of the adiponectin testing market. Furthermore, the increasing epidemic of obese populations of all ages has also been stimulating the clinical studies on adiponectin levels in the body. Also, adiponectin testing has been rising in the use for livestock.
Manufacturers of testing kits are determined to increase their product portfolio in the adiponectin testing market, and several have entered into the latest product launches and acquisitions. They have also garnered scientific backing based on a meta-analysis of the clinical potential of adiponectin. Moreover, they have been obtaining from the epidemiology survey with the aim of sustaining the diagnostic potential of products in the adiponectin testing market.
The introduction of functional food ingredients that claim to progress adipocyte health and adiponectin metabolism has increased the opportunities for market players. Throughout the years, studies that focus on the meta-analysis of the hormone as a biomarker for the diagnosis of metabolic syndrome have gained steam, thus enhancing the adiponectin testing market. The newest development and advancement in laboratory infrastructure for such tests have driven investment in the adiponectin testing market.
Global Adiponectin Testing Market: Segmentation
The global adiponectin testing market is classifying on the basis of product type, and application. Based on the type, the market is divided into ELISA testing, enzyme immunoassay testing, and others. In terms of application, the adiponectin testing market is segmented into the hospital, specialty clinics, diagnostics laboratories, and others.
Global Adiponectin Testing Market: Regional Analysis
The adiponectin testing market has been witnessing sizable avenues in the regions of North America, Europe, Latin America, Oceania, Asia, and the Middle East and Africa. In terms of region, North America has been contributing the largest share of growth to the global adiponectin testing market. The development can be apportioned to the growing potential of adipose-based products in reinforcing the drug pipelines for treating metabolic syndrome. Also, Asia-Pacific countries with the expanding medical tourism have been showing great potential in the adiponectin testing market.
Global Adiponectin Testing Market: Competitive Players
Some major players in the global adiponectin testing market are Stratec SE, Bio-Rad Laboratories, Thermo Fisher Scientific Inc., Merck KGaA, Eagle Biosciences, Boster Biological Technology, and LabCorp.
For example, Laboratory Corporation of America Holdings, more commonly known as Labcorp operates one of the largest clinical laboratory networks in the world, with a United States network of 36 primary laboratories. In March 2020, Labcorp received emergency use authorization from the FDA for a test for 2019-nCov to help mitigate the COVID-19 pandemic. And it is one of the six large commercial lab companies that are conducting most of the United States' coronavirus testing along with ARUP, BioReference Laboratories, Mayo Clinic, Quest Diagnostics, and Sonic Healthcare.
Global Adiponectin Testing Market: By Type
Global Adiponectin Testing Market: By Application
Global Adiponectin Testing Market: Regional Segmentation Analysis
Frequently Asked Questions
What are the key factors driving global adiponectin testing market expansion?
The drug manufacturers have been focusing on new drug targets for insulin resistance (IR)-related metabolic disorders, which is driving the industry interest in adiponectin testing. Also, the rising demand for the population for the diagnosis of hypoadiponectinemia has boosted the possibility of the adiponectin testing market.
What will be the value of the adiponectin testing market during 2021- 2026?
The global demand for the adiponectin testing market was estimated at approximately USD 1,905.2 Million in 2020 and is expected to generate revenue of around USD 2,600.6 Million by end of 2026, growing at a CAGR of around 5.6% between 2021 and 2026.
Which region will make notable contributions towards global adiponectin testing market revenue?
In terms of region, North America has been contributing the largest share of growth to the global adiponectin testing market.
What are the key players leveraging adiponectin testing market growth?
Some major players in the global adiponectin testing market are Stratec SE, Bio-Rad Laboratories, Thermo Fisher Scientific Inc., Merck KGaA, Eagle Biosciences, Boster Biological Technology, and LabCorp.
Adiponectin Testing
Adiponectin Testing
×